Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000057593) titled 'Novel Fecal Biomarker for Irritable Bowel Syndrome' on Oct. 1.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: Tohoku University
Condition:
Patients with Irritable Bowel Syndrome and Healthy Subjects
Recruitment Status: Not Recruiting
Phase: Not applicable
Date of First Enrollment: 2025/10/01
Target Sample Size: 100
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065800
Published by HT Digital Content Services with permission from Health Daily Digest....